NCT00005921View on ClinicalTrials.gov

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

Not specified

Conditions
Candidiasis, EsophagealHIV Infections
Interventions
DRUG

L-743,872

Trial Locations (1)

07065

Gary Calandra, Rahway

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00005921 - A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis | Biotech Hunter | Biotech Hunter